Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2009
10/06/2009US7598356 Performed in a relatively short period of time, involves inexpensive reagents, and requires little sample preparation before and during the purification process
10/06/2009US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/06/2009US7598354 Campylobacter glycans and glycopeptides
10/06/2009US7598352 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/06/2009US7598349 Antibodies to peptide fragments having cell death-inhibitory activity
10/06/2009US7598348 Adiponectin receptor variant, AdipoR2v2
10/06/2009US7598347 RGD-enriched gelatines
10/06/2009US7598346 Antifungal polypeptides
10/06/2009US7598345 Immunostimulatory compositions and methods
10/06/2009US7598344 bi-functionally-linked biopolymer, wherein the functional linkage is between a biomaterial surface and cells or biologic molecules; takes advantage of molecular screening methods to prepare molecular structures with specific binding motifs and/or b
10/06/2009US7598343 have a maximum impurity level of Asp9-bivalirudin that does not exceed about 0.6%; anticoagulant ; batches have a pH adjusted by a base sodium hydroxide about 5-6; Hirulog-8; thrombin peptide inhibitor
10/06/2009US7598342 Alpha-fetoprotein peptides and uses thereof
10/06/2009US7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
10/06/2009US7598229 Metastatic colorectal cancer vaccine
10/06/2009US7598226 Compositions and methods for the therapy and diagnosis of breast cancer
10/06/2009US7598225 Generation of immune response to prostate-specific antigen (PSA)
10/06/2009US7598224 Have a hydrophobic linker region and a heparin-binding region, useful as soluble biologics or as surface coatings for medical devices
10/06/2009US7598222 Process for solubilizing glucagon-like peptide 1 compounds
10/06/2009US7598221 Synthetic HLA binding WT-1 peptide analogues and uses thereof
10/06/2009US7598084 Polynucleotide isolated from Eucalyptus and Pinus; useful regulating polysaccharide synthesis and plant phenotype; transgenic cells and plants of Eucalyptus and Pinus
10/06/2009US7598078 Deliver a heterologous nucleic acid sequence in prime-boost vaccination regimens; sequence encodes the same gene product or antigen in the recombinant adenovirus vector of the first and second serotype; viral antigens are Ebola, measles, West Nile, HIV, SIV; cross neutralization not an issue
10/06/2009US7598068 Genetic engineered protein; biosynthesis from glucuronic acid and N-acetylgalactosamine
10/06/2009US7598062 Process for the production of L-amino acids using strains of the family enterobacteriaceae that contain an attenuated fruR gene
10/06/2009US7598059 Neublastin expression constructs
10/06/2009US7598058 Nucleic acids encoding IL13 mutants
10/06/2009US7598057 Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
10/06/2009US7598056 Factor VII or VIIA-like molecules
10/06/2009US7598055 N-acetylglucosaminyltransferase III expression in lower eukaryotes
10/06/2009US7598051 Ovarian carcinoma polypeptides having a specific amino acid sequence, its fusion proteins and polynucleotides encoding them; cancer vaccines
10/06/2009US7598050 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
10/06/2009US7598048 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions
10/06/2009US7598045 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer
10/06/2009US7598042 Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use
10/06/2009US7597905 Hollow nanoparticle for use in the transfer of biopolymer into cells
10/06/2009US7597904 casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria containing Lactobacillus helveticusto provide a fermented dairy product containing metalloproteinases inhibitory agent
10/06/2009US7597896 Composition comprising a protein encoded by a modified ERP gene of Mycobacterium
10/06/2009US7597895 Peptide or antibody that competitively inhibits binding of CSP (competence signal peptide) to Streptococcus mutans histidine kinase; endocarditis
10/06/2009US7597894 Antigen presenting cells and dendritic cells; inducing immunology response
10/06/2009US7597888 nucleic acid molecules and polypeptide molecules that encode glycoprotein VI; modulating agents in regulating a variety of cellular processes
10/06/2009US7597887 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1)
10/06/2009US7597886 Tumor necrosis factor-gamma
10/06/2009US7597884 Hyperglycosylated polypeptide variants and methods of use
10/06/2009US7597883 Methods for promoting growth of bone, ligament, and cartilage
10/06/2009US7597882 precursor containing a biocompatible liquid crosslinker polyethylene glycol with at least three activated acid functional groups that are strong electrophiles selected from succinimide, succinimidee ester, N-hydroxysuccinimide ester and maleimide; a ; covalently crosslink proteins; biomaterial; sealant
10/06/2009US7597875 Diaminedioxime radiometal complexes
10/06/2009CA2381348C Lck-derived peptides activating ctls
10/06/2009CA2381323C Amyloid .beta. protein (globular assembly and uses thereof)
10/06/2009CA2284689C Animal model for evaluation of vaccines
10/06/2009CA2245151C Improved process for obtaining insulin precursors having correctly bonded cystine bridges
10/06/2009CA2218129C Chimeric mcp and daf proteins with cell surface localizing domain
10/06/2009CA2167910C Aqueous multiple-phase isolation of polypeptide
10/06/2009CA2159106C Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
10/06/2009CA2111205C Polypeptides having kinase activity, their preparation and use
10/01/2009WO2009121024A2 Methods for detecting antibodies
10/01/2009WO2009120993A2 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof
10/01/2009WO2009120893A2 Polypeptide-polymer conjugates and methods of use thereof
10/01/2009WO2009120831A2 Novel n-and c-terminal substituted antagonistic analogs of gh-rh
10/01/2009WO2009120313A2 Identification of human t2r receptors that respond to bitter ligands in soy and related assays for identifying bitter taste modulators
10/01/2009WO2009120306A1 Multivalent vaccine vector for the treatment and inhibition of viral infection
10/01/2009WO2009120043A2 Use for cd45+ cells or a cd45+ cell culture fluid for promoting the growth of mesenchymal stem cells
10/01/2009WO2009119792A1 GHRELIN AND DERIVATIVE THEREOF, OR THERAPEUTIC AGENT FOR CHRONIC RESPIRATORY TRACT INFECTIONS COMPRISING GROWTH HORMONE SECRETAGOGUE RECEPTOR 1a AGONIST AS ACTIVE INGREDIENT
10/01/2009WO2009119782A1 Modified photoreceptor channel type rhodopsin protein
10/01/2009WO2009119596A1 Method of classifying proteins, method of dissolving proteins, method of fractionating and collecting non-animal fiber and proteins originating in animal fiber
10/01/2009WO2009119455A1 Cancer cell motility and cancer cell infiltration inhibitor
10/01/2009WO2009118778A1 Method of separating fish immature germ cell using fish immature germ cell surface-specific protein
10/01/2009WO2009118734A2 Coral-derived collagen and methods of farming same
10/01/2009WO2009118710A2 Cd4-related polypeptides and methods of use
10/01/2009WO2009118626A1 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3
10/01/2009WO2009118273A1 Compositions, methods and kits
10/01/2009WO2009118191A2 Therapy for vitiligo
10/01/2009WO2009118185A1 Peptides derived from cardial troponin i and their use as prognostic and diagnostic markers for heart failure
10/01/2009WO2009117853A1 Method for cultivating plants having increased ability of nitrogen uptake
10/01/2009WO2009117821A1 Compositions and methods related to silicon transport
10/01/2009WO2009117773A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
10/01/2009WO2009100127A3 Isolated brca1 peptides and method of use
10/01/2009WO2009098682A3 Methods and compositions for treatment of mitochondrial disorders
10/01/2009WO2009098656A3 Method for predicting or diagnosing outcome of intracranial tumors in a subject
10/01/2009WO2009098596A3 Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics
10/01/2009WO2009094527A3 Transcriptional activators involved in abiotic stress tolerance
10/01/2009WO2009093253A3 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
10/01/2009WO2009090330A3 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections
10/01/2009WO2009086309A3 Cell culture processes
10/01/2009WO2009044383A8 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
10/01/2009WO2009022236A8 Immunogen platform
10/01/2009WO2009022236A3 Immunogen platform
10/01/2009WO2008103471A9 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/01/2009WO2008051306A8 Soluble tnf receptors and their use in treatment of disease
10/01/2009WO2008017636A8 Genes and proteins of brachyspira hyodysenteriae and uses thereof
10/01/2009WO2007141346A9 Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases
10/01/2009WO2002074916A9 Reg-like protein immunoglobulin derived proteins, compositions, methods and uses
10/01/2009US20090249517 Alteration of Oil Traits in Plants
10/01/2009US20090249499 Sperm-specific cation channel, catsper4, and uses therefor
10/01/2009US20090247734 Chemically Derivatized CD4 and Uses Thereof
10/01/2009US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems
10/01/2009US20090247732 Synthesis of glycopeptides with superior pharmacokinetic properties
10/01/2009US20090247610 Integrase cofactor
10/01/2009US20090247608 Targeting Lipids
10/01/2009US20090247482 50 Human Secreted Proteins
10/01/2009US20090247463 Polymer-based sustained release device
10/01/2009US20090247462 Fgf variants and methods for use thereof
1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 2916